 | | | | Slovakia's government will extend its state of emergency powers for the rest of the year to battle a surge in new coronavirus cases, Justice Minister Maria Kolikova said on Wednesday. | | |
| | | The European Commission said on Wednesday it had sealed a deal with Pfizer and BioNTech for the supply of up to 300 million doses of their COVID-19 vaccine candidate. | | |
| | | Uzbekistan will carry out a phase III trial of a coronavirus vaccine candidate developed by China's Anhui Zhifei Longcom Biopharmaceutical Co., the Central Asian nation's ministry of innovative development told Reuters on Wednesday. | | |
| | | Total coronavirus infections in Nepal crossed 200,000 on Wednesday, as health workers say the Himalayan nation was facing a "catastrophic" situation. | | |
| | | Here's what you need to know about the coronavirus right now: | | |
| | | Pfizer Inc and German partner BioNTech SE said on Wednesday they had reached an agreement with the European Commission to supply up to 300 million doses of their experimental coronavirus vaccine. | | |
| | | Coronavirus infections rose by 8,270 cases in a day, data from Swiss health authorities showed on Wednesday. | | |
| | | Chinese firm Tibet Rhodiola Pharma holding said on Wednesday that it has obtained non-exclusive right to develop, manufacture, import or commercialize Russia's COVID-19 vaccine, Sputnik V, in mainland China, Hong Kong, Macau and Taiwan. | | |
| | | Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot. | | |
| | | Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot. | | |
| | | Britain is ready to roll out tens of millions of COVID-19 vaccines to the public with care-home residents and the elderly first in line for a jab that medics hope will allow the world to return to some semblance of normality. | | |
|
| |
